Yves St-Pierre Selected Research

Galectins (Galectin)

11/2021	Galectins in Glioma: Current Roles in Cancer Progression and Future Directions for Improving Treatment.
1/2021	Towards a Better Understanding of the Relationships between Galectin-7, p53 and MMP-9 during Cancer Progression.
1/2018	The emerging role of galectins in high-fatality cancers.
10/2017	Tissue and plasma levels of galectins in patients with high grade serous ovarian carcinoma as new predictive biomarkers.
4/2016	Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
12/2015	Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.
11/2014	Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells.
4/2014	Intracellular galectins in cancer cells: potential new targets for therapy (Review).
1/2013	Expression of galectin-7 is induced in breast cancer cells by mutant p53.
1/2012	A distinctive role for galectin-7 in cancer ?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yves St-Pierre Research Topics

Disease

28	Neoplasms (Cancer) 11/2021 - 09/2002
8	Breast Neoplasms (Breast Cancer) 01/2017 - 04/2010
8	Neoplasm Metastasis (Metastasis) 08/2014 - 03/2004
8	Lymphoma (Lymphomas) 08/2010 - 10/2002
4	Inflammation (Inflammations) 11/2011 - 06/2001
3	Glioma (Gliomas) 11/2021 - 08/2002
2	Carcinoma (Carcinomatosis) 01/2021 - 10/2017
2	Ovarian Neoplasms (Ovarian Cancer) 10/2017 - 09/2014
2	Melanoma (Melanoma, Malignant) 01/2013 - 06/2007
2	Hematologic Neoplasms (Hematological Malignancy) 01/2011 - 01/2010
2	Infections 05/2005 - 06/2001
1	Albuminuria 10/2020
1	Disease Progression 04/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Nevus (Nevi) 01/2013
1	Pathologic Processes 11/2011
1	Lung Neoplasms (Lung Cancer) 05/2010
1	Eczema 05/2010
1	Stomach Neoplasms (Stomach Cancer) 05/2010
1	Asthma (Bronchial Asthma) 05/2010
1	Triple Negative Breast Neoplasms 04/2010
1	Joint Diseases (Joint Disease) 08/2007
1	Rheumatoid Arthritis 08/2007
1	Experimental Melanoma 06/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2007
1	Arthritis (Polyarthritis) 01/2006
1	Carcinogenesis 06/2005
1	T-Cell Lymphoma (Lymphoma, T Cell) 06/2005

Drug/Important Bio-Agent (IBA)

16	Galectins (Galectin)IBA 11/2021 - 06/2005
7	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 03/2004
6	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2015 - 09/2002
6	Proteins (Proteins, Gene)FDA Link 04/2014 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2007
5	Messenger RNA (mRNA)IBA 01/2017 - 10/2002
5	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2005 - 06/2001
4	LigandsIBA 04/2014 - 05/2005
4	Protein Isoforms (Isoforms)IBA 01/2014 - 09/2002
3	Carrier Proteins (Binding Protein)IBA 01/2017 - 06/2010
3	EnzymesIBA 08/2014 - 11/2011
3	DNA (Deoxyribonucleic Acid)IBA 08/2014 - 09/2009
3	Interleukin-1 (Interleukin 1)IBA 09/2004 - 08/2002
2	Pharmaceutical PreparationsIBA 11/2021 - 06/2009
2	Interleukin-6 (Interleukin 6)IBA 10/2020 - 09/2004
2	CarbohydratesIBA 01/2015 - 01/2011
2	Epidermal Growth Factor (EGF)IBA 01/2015 - 08/2010
2	Biological ProductsIBA 01/2015 - 01/2005
2	RNA (Ribonucleic Acid)IBA 08/2014 - 09/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 09/2009
2	SelectinsIBA 01/2010 - 06/2005
2	L-SelectinIBA 01/2010 - 06/2005
2	Complementary DNA (cDNA)IBA 03/2007 - 05/2005
2	Peptide Hydrolases (Proteases)FDA Link 05/2005 - 06/2001
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2002 - 08/2002
1	AngiotensinogenIBA 10/2020
1	Interleukin-10 (Interleukin 10)IBA 10/2020
1	Type 1 Angiotensin ReceptorIBA 10/2020
1	ReninIBA 10/2020
1	AlarminsIBA 01/2018
1	AntigensIBA 10/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 04/2016
1	Bone Morphogenetic Protein 4IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2015
1	Phenobarbital (Luminal)FDA Link 11/2014
1	matrigelIBA 09/2014
1	Tumor Biomarkers (Tumor Markers)IBA 08/2014
1	GlycoconjugatesIBA 04/2014
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2014
1	Estrogen ReceptorsIBA 01/2013
1	LectinsIBA 01/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	Early Growth Response Protein 1IBA 08/2010
1	GalactosidesIBA 06/2010
1	ORALIT (ORS)IBA 05/2010
1	Indicators and Reagents (Reagents)IBA 04/2010
1	glembatumumab vedotinIBA 04/2010
1	Immunoconjugates (Immunoconjugate)IBA 04/2010
1	Glycoproteins (Glycoprotein)IBA 04/2010
1	Phorbol EstersIBA 01/2010
1	Galectin 1 (LGALS1)IBA 06/2009
1	Galectin 3 (LGALS3)IBA 06/2009
1	14-3-3 Proteins (14-3-3 Protein)IBA 08/2007
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 06/2007
1	CalciumIBA 06/2007
1	Phospholipase DIBA 06/2007
1	Matrix Metalloproteinase InhibitorsIBA 01/2006
1	C-Reactive ProteinIBA 01/2006
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2006
1	Lactose FDA LinkGeneric 06/2005
1	Cell Adhesion MoleculesIBA 05/2005
1	Protect-ItIBA 01/2005
1	Interleukin-4 (Interleukin 4)IBA 09/2004
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 09/2004
1	CytokinesIBA 09/2004
1	Interleukin-13IBA 09/2004

Therapy/Procedure

2	Therapeutics 04/2014 - 04/2010
1	Immunotherapy 11/2021
1	Drug Therapy (Chemotherapy) 10/2017
1	Subcutaneous Injections 01/2013